Literature DB >> 7093974

Phase II evaluation of gallium nitrate in breast cancer: a Southwest Oncology Group Study.

C J Fabian, L H Baker, C B Vaughn, H E Hynes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7093974

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

1.  Phase II evaluation of gallium nitrate by continuous infusion in breast cancer.

Authors:  K Jabboury; D Frye; F A Holmes; G Fraschini; G Hortobagyi
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

Review 2.  Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?

Authors:  Mukundan Baskar Mannargudi; Subrata Deb
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-17       Impact factor: 4.322

3.  Long-term oncologic safety of immediate reconstructive surgery in patients with invasive breast cancer: a retrospective matched-cohort study.

Authors:  Yanni Song; Shanshan Sun; Dalin Li; Jiguang Han; Ming Niu; Sai Luo; Haiqian Xu; Rui Huang; Sihang Zhang; Yang Wu; Qiqi Wu; Jing Xiong; Lijun Hao
Journal:  World J Surg Oncol       Date:  2021-12-20       Impact factor: 2.754

4.  Gallium citrate, a new sensitizer of cells to hyperthermia.

Authors:  K Shinohara; N Kawakami; M Kugotani; H Nakano
Journal:  Jpn J Cancer Res       Date:  1988-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.